2 results
Approved WMOPending
To evaluate the efficacy of AD 923 in comparison to MSIR in the management of breakthrough pain in subjects with malignicies who are taking a stable dose of background opioids.
Approved WMORecruiting
To find a simple test to explain non-responsiveness to sumatriptan in a proportion of patients with migraine.